Press Releases

Press Releases

Oct 21, 2020

CRISPR Therapeutics Reports Positive Top-Line Results from Its Phase 1 CARBON Trial of CTX110™ in Relapsed or Refractory CD19+ B-cell Malignancies

Oct 07, 2020

CRISPR Therapeutics Congratulates Co-Founder Emmanuelle Charpentier on Receiving the 2020 Nobel Prize in Chemistry

Sep 29, 2020

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Sep 22, 2020

CRISPR Therapeutics and Vertex Pharmaceuticals Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency (EMA) to CTX001™ for the Treatment of Sickle Cell Disease

Sep 03, 2020

CRISPR Therapeutics to Present at the Wells Fargo 2020 Virtual Healthcare Conference

Jul 30, 2020

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Jul 27, 2020

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial Results

Jun 30, 2020

CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares

Jun 29, 2020

CRISPR Therapeutics Announces Proposed Offering of Common Shares

Jun 25, 2020

CRISPR Therapeutics Announces the Build-Out of New Cell Therapy Manufacturing Facility

Jun 12, 2020

CRISPR Therapeutics and Vertex Announce New Clinical Data for Investigational Gene-Editing Therapy CTX001™ in Severe Hemoglobinopathies at the 25th Annual European Hematology Association (EHA) Congress

May 26, 2020

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

May 15, 2020

CRISPR Therapeutics Announces Presentations at the American Association for Cancer Research 2020 Annual Meeting

May 14, 2020

New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001™ for Severe Hemoglobinopathies Accepted for Oral Presentation at the 25th European Hematology Association (EHA) Congress

May 11, 2020

CRISPR Therapeutics and Vertex Pharmaceuticals Announce FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX001™ for the Treatment of Severe Hemoglobinopathies

May 07, 2020

CRISPR Therapeutics to Present at the Bank of America Securities 2020 Health Care Conference

Apr 28, 2020

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2020 Financial Results

Feb 26, 2020

CRISPR Therapeutics Proposes Changes to the Board of Directors

Feb 12, 2020

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results

Jan 06, 2020

CRISPR Therapeutics to Present at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top Conference